YOUR CHILD DESERVES
TO DU MORE

What could your child DU With Less Asthma? See the results to learn how DUPIXENT helped.

Benefits with Every Breath

DUPIXENT was proven to improve lung function and help prevent asthma attacks in children 6-11 years.
DUPIXENT is not a steroid but can help reduce oral steroid use.

DUPIXENT was studied in a clinical trial with 408 children 6 to 11 years old with uncontrolled moderate-to-severe asthma.

Improved lung function
IN CHILDREN IN AS LITTLE AS

65% FEWER
ASTHMA ATTACKS*

*The annual rate of severe asthma attacks
was 0.24 with DUPIXENT 100mg/200mg
vs 0.67 with placebo.

66% reduction in
steroid bursts

Do not stop taking your corticosteroid
medicines unless instructed by your
healthcare provider. This may cause other
symptoms that were controlled by the
corticosteroid medicine to come back.

The safety results of DUPIXENT observed in children through Week 52 were similar to the safety profile from studies in adults and adolescents with moderate-to-severe asthma with the addition of parasitic (helminth) infections.

What You Should Know About the Patients in These Studies:

9

Average age

≈79.4 lbs

Average weight

2.4

Average number
of attacks in
previous year

44%

On high‑dose
inhaled
corticosteroids

DUPIXENT had a
demonstrated safety
profile in clinical trials

The most common side effects include:

  • Injection site reactions
  • High count of a certain white
    blood cell (eosinophilia)
  • Pain in the throat
    (oropharyngeal pain)
  • Parasitic (helminth) infections

View the possible side effects of DUPIXENT in patients with moderate-to-severe
eosinophilic or oral corticosteroid dependent asthma.

RESULTS IN PATIENTS 12+ YEARS

DUPIXENT was also proven to improve lung function and prevent asthma attacks in patients 12+ years.

HAVE A PRODUCTIVE CONVERSATION WITH YOUR DOCTOR

Personalize your doctor discussion guide

Our goal is for you or your loved one to get the most out of your visit to the doctor. Fill out our personalized discussion guide to help you have a productive conversation during your next visit.

Go to the DUPIXENT Dosing for
Asthma page to learn more about
dosing and administration options.

frequently asked questions

In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Patients in the DUPIXENT groups saw improved lung function in as little as 2 weeks.

Learn how DUPIXENT helped treat patients 12+ years old with their moderate-to-severe asthma.

RESULTS IN PATIENTS
AGES 12+ YEARS